An example of this would be the previously mentioned patient with MS who has similar MRI findings and similar clinical symptoms, however with a much higher elevated NfL level (as opposed to the first scenario) that remains elevated when compared to prior baseline. This evidence concerns the gene NEFL and myeloid sarcoma.